Abstract: The invention provides, inter alia, methods for treating vascular deficiencies, including those in diabetic subjects, by transplanting endothelial progenitor cells with transiently reduced p53 expression.
Abstract: The invention provides, inter alia, methods for treating vascular deficiencies, including those in diabetic subjects, by transplanting endothelial progenitor cells with transiently reduced p53 expression.
Abstract: The invention provides, inter alia, methods for treating vascular deficiencies, including those in diabetic subjects, by transplanting endothelial progenitor cells with transiently reduced p53 expression.
Abstract: A cytology device and a method of use thereof are described. The cytology scraper comprises a scraping element that provides increased tissue removal capabilities over conventional cytology brushes. The edges of the scraping element can also simultaneously dilate strictures during the tissue removal procedure.
Type:
Grant
Filed:
December 9, 2008
Date of Patent:
December 6, 2011
Assignees:
Cook Medical Technologies LLC, Baystate Health, Inc.
Abstract: A balloon endoscope device having a shaft with a distal end that allows for blunt dissection is provided. The shaft utilizes a plurality of separately inflatable balloons that alone or together with exterior functional channels (e.g., instrument channels, air channels, water channels, suction channels) circumferentially surround the distal end of the shaft to better position and maneuver the distal end as it advances through tissue planes and once it reaches a target working space or operative site.
Abstract: The invention relates to the use of phospholipase C zeta in inducing or promoting the activation of oocytes, preferably human oocytes, nuclear transfer embryos, parthenogenic embryos, cross species embryos and during in vitro fertilization. The invention further relates to methods of detecting levels of expression of phospholipase c zeta in sperm as a means of detecting male infertility. The invention also relates to the use of phospholipase C zeta to treat male infertility. Still further the invention relates to the recombinant cells that are engineered to express phospholipase C zeta, preferably under inducible conditions. Also, the invention relates to antibodies specific to phospholipase C zeta, preferably human phospholipase C zeta.
Type:
Application
Filed:
November 19, 2007
Publication date:
July 24, 2008
Applicants:
Michigan State University, University of Massachussetts, Baystate Health, Inc.
Inventors:
Rafael A. Fissore, Pablo Visconti, Manabu Kurokawa, Sook-Young Yoon, Daniel R. Grow, Teru J. Jellerette, Jose Bernardo Cibelli, Pablo Juan Ross